A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine

Completed · Phase 1

Conditions studied: Migraine

In brief

The purpose of the study is the measure the levels of lasmiditan in the body of children aged 6 to 17 with migraine. The study also will also examine the safety and tolerability of lasmiditan in children aged 6 to 17 with migraine. The study will last about 6 weeks, and includes 4 visits.

Key facts

Study ID
NCT03988088
Run by
Eli Lilly and Company
People needed
18
Starts
2019-07-22
Expected to finish
2020-02-24
Last updated by the study team
2020-09-01

Who can join

Age: 6 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.